Solutions are now available that help integrate microbial testing results with the rest of the company through the integration of automated, growth-based, rapid microbial method (RMM) technologies with laboratory information management systems (LIMS)
In addition to the rise of lean initiatives throughout the last few decades, businesses in most industries have transitioned from using siloed, departmental technologies toward more integrated systems. Pharmaceutical quality control labs have been slow to integrate with the rest of the business, often due to a lack of available technologies. However, solutions are now available that help integrate microbial testing results with the rest of the company.
These connections can be accomplished through the integration of automated, growth-based, rapid microbial method (RMM) technologies with laboratory information management systems (LIMS). By connecting these two technologies, users can realise the following benefits:
Given so many far-reaching benefits, it only makes sense that LIMS integration should be an important capability of the Growth Direct System. Because the integration of systems is typically handled via a company’s IT department, it is important to engage the IT resources early as part of the implementation. Current Growth Direct System customers have found that working closely with their IT departments and using a reference computer to test the integration can help streamline the implementation and validation process.
A more efficient QC lab can potentially create more cost effective, scalable business operations for pharmaceutical manufacturers. To learn more about the bottom-line benefits of LIMS integration and other features of growth-based, automated RMM, download our free resource, 'Quantifying the Economic Benefits of the Growth Direct System', today.